Marta Roman

Synthetic Vulnerabilities in the KRAS Pathway

E. A. Sweet-Cordero, M. Roman, Elizabeth Hwang, 2022, Cancers.

The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas

Jun Lu, P. Mazur, N. Flores, 2019, The Journal of clinical investigation.

Id1 and PD-1 Combined Blockade Impairs Tumor Growth and Survival of KRAS-mutant Lung Cancer by Stimulating PD-L1 Expression and Tumor Infiltrating CD8+ T Cells

S. Vicent, C. Rolfo, J. Lasarte, 2020, Cancers.

KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target

S. Vicent, C. Rolfo, I. López, 2018, Molecular Cancer.

Inhibitor of Differentiation-1 Sustains Mutant KRAS-Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 Network.

I. Wistuba, S. Vicent, C. Behrens, 2018, Cancer research.

The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche.

C. Rolfo, L. Raez, E. Castañón, 2017, Cancer letters.

Pazopanib-induced asymptomatic radiological acute pancreatitis: A case report

C. Rolfo, J. Pérez-Gracia, I. Gil-Bazo, 2017, Molecular and clinical oncology.

Textbook outcome and survival after gastric cancer resection with curative intent: A population-based analysis.

A. Luna, D. Momblán, E. Garsot, 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma

A. Califano, Stanley G. Leung, Alex G. Lee, 2023, Nature communications.

KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target

S. Vicent, C. Rolfo, I. López, 2018, Molecular Cancer.

Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer

P. Khatri, F. Lecanda, M. Drosten, 2023, Nature communications.